KYLE HODGES: Open Payments
NPI 1821420126 · OAKLEY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 11 payments from 6 companies in 2025. Trend: 2023 $96 · 2024 $156 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Lilly USA, LLC | 2 | $29 |
| Grifols USA, LLC | 1 | $25 |
| Organogenesis Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $15 |
Products named: FARXIGA, EVENITY, OTEZLA, MOUNJARO, Prolastin-C Liquid, CYGNUS DUAL, Ozempic.
Industry payments across KS — which companies pay providers there.
